Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

View Slides

Literature Highlights - November 2024

more…

Keywords:

systemic lupus erythematosus, randomized clinical trial, belimumab, disease activity, patient-reported outcomes, disease trajectories, Efficacy, Iberdomide, Phase 2, Safety, CLE,, SLE, Type 2 diabetes, Cardiovascular, Renal, SGLT2i

October 2021

View Slides

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus

Arthritis Rheumatol 2017;69:376–86

One of the challenges of treating SLE is the limited efficacy and poor tolerability of current therapies.

more…

Keywords:

Systemic Lupus Erythematosus,
Anifrolumab,
Phase 2